Skip to content

Juno Therapeutics started at buy by Wells Fargo

February 26, 2017

Equities researchers at Wells Fargo & Company assumed coverage on shares of Juno Therapeutics Inc (NDAQ:JUNO) in a research note issued to investors on Wednesday. The firm set an “outperform” rating on the stock.

http://bit.ly/2lngRwf

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out / Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out / Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out / Change )

Google+ photo

You are commenting using your Google+ account. ( Log Out / Change )

Cancel

Connecting to %s

«
»
%d bloggers like this: